A federal judge has ordered Aetna Life Insurance Co. to reconsider its denials of gender-affirming facial surgery coverage for transgender patients, temporarily blocking the insurer from enforcing a policy that categorically excludes those procedures as cosmetic.
The ruling comes in a lawsuit brought by transgender women who argue that Aetna’s policy discriminates against them by denying coverage for medically necessary facial feminization procedures used to treat gender dysphoria.
U.S. District Judge Victor A. Bolden of the District of Connecticut granted a preliminary injunction preventing Aetna from automatically denying coverage for certain gender-affirming facial surgeries. The decision requires the insurer to reassess the plaintiffs’ requests under the same medical necessity standards used for other reconstructive procedures.
The case challenges Aetna’s Clinical Policy Bulletin 0615, which labels several facial procedures commonly used in facial feminization surgery as cosmetic when performed for gender transition. These procedures can include brow bone contouring, hairline advancement, and other structural facial modifications.
According to the plaintiffs, the policy forces transgender patients to pay tens of thousands of dollars out of pocket or go without treatment that physicians consider medically necessary.
Judge Bolden said the plaintiffs showed a strong likelihood that the policy violates Section 1557 of the Affordable Care Act, which prohibits discrimination in health care programs receiving federal funding.
In the decision, the court wrote that the denial of medically necessary gender-affirming treatment could result in serious health consequences for transgender patients, including psychological harm associated with untreated gender dysphoria.
The judge concluded that blocking the policy while the lawsuit proceeds is necessary to prevent irreparable harm to the plaintiffs.
The lawsuit was filed as a proposed class action on behalf of transgender women who were denied coverage for facial feminization surgery under Aetna’s policies. Attorneys representing the plaintiffs argue that the insurer routinely covers comparable reconstructive procedures for other medical conditions but denies them when they are related to gender transition.
The court’s order currently applies to two of the individuals involved in the case. However, the broader lawsuit remains active and could expand to include additional policyholders affected by the exclusion.
If the plaintiffs ultimately succeed, the case could require insurers to evaluate gender-affirming facial surgery requests individually rather than applying blanket exclusions that automatically deny coverage.
Legal experts say the ruling reflects growing scrutiny from courts over insurance policies that exclude transgender-related care, particularly when similar treatments are covered for other patients.
Aetna has not publicly outlined how it will respond to the injunction but previously stated that it supports the health care needs of LGBTQ members while declining to comment on active litigation.
The case will continue in federal court as the judge considers whether Aetna’s policy violates federal nondiscrimination protections and whether broader relief should be granted to transgender patients seeking gender-affirming care.
